Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Radiomics-based Differentiation of Recurrent Brain Metastases from Treatment Effects: A Multi-Institutional Comparative Study with Advanced Imaging.
Journal: Radiology. Imaging cancer
Published: April 17, 2026
Machine learning-based prognostic subgrouping of glioblastoma: A multicenter study.
Journal: Neuro-oncology
Published: December 12, 2024
Locoregional CAR T Cells for the Treatment of CNS Tumors in Children: Investigational Drug Service Pharmacy Activities.
Journal: Journal of hematology oncology pharmacy
Published: September 06, 2024
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 25, 2024
Propofol Inhibits Glioma Stem Cell Growth and Migration and Their Interaction with Microglia via BDNF-AS and Extracellular Vesicles.
Journal: Cells
Published: April 24, 2023
Endoglin inhibitor TRC105 with or without bevacizumab for bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase II trial.
Journal: Communications medicine
Published: February 22, 2023
An optimized approach and inflation media for obtaining complimentary mass spectrometry-based omics data from human lung tissue.
Journal: Frontiers in molecular biosciences
Published: August 18, 2022
Neurosurgery's Impact on Neuro-Oncology-"Can We Do Better?"-Lessons Learned Over 50 Years.
Journal: Neurosurgery
Published: January 05, 2022
Association of metabolic syndrome with glioblastoma: a retrospective cohort study and review.
Journal: Neuro-oncology practice
Published: October 05, 2020
Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors.
Journal: Investigational new drugs
Published: May 17, 2020
Hemolytic anemia associated with dapsone PCP prophylaxis in GBM patients with normal G6PD activity.
Journal: Neuro-oncology
Published: February 13, 2020
Last Updated: 09/26/2026